Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High?

Shares of Jazz Pharmaceuticals (JAZZ) have gained 15.4% over the past four weeks to close the last trading session at $143.53, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$186.06 indicates a potential upside of 29.6%.The average comprises 18 short-term price targets ranging from a low of $128 to a high of$230, with a standard deviation of $26.62. While the lowest estimate i ...